Moreover, patients with specific combinations of CMD, such as hypertension and diabetes or hypertension and heart disease, showed significantly elevated levels of tau-related biomarkers, particularly if they had a longer disease course. The gene discussed is MAPT; the disease is diabetes mellitus.